Agency Forms Undergoing Paperwork Reduction Act Review, 43875-43876 [2018-18588]
Download as PDF
<![CDATA[
Federal Register / Vol. 83, No. 167 / Tuesday, August 28, 2018 / Notices
HISTORY:
The history of the Board’s various
systems can be located at: https://
www.federalreserve.gov/system-ofrecords-notices.htm by clicking on the
Federal Register Notice associated with
the SORN for each system. In order that
the Board’s General Routine Uses will
be contained in a single notice readily
accessible by the public, the Board is
taking the opportunity to republish the
General Routine Uses previously
published on May 6, 2008 (73 FR 24985)
which were not revised under this
notice.
Board of Governors of the Federal Reserve
System, August 23, 2018.
Ann Misback,
Secretary of the Board.
[FR Doc. 2018–18627 Filed 8–27–18; 8:45 am]
BILLING CODE P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Proposed Project
[30Day–18–1102]
daltland on DSKBBV9HB2PROD with NOTICES
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled Information
Collection for Tuberculosis Data from
Panel Physicians to the Office of
Management and Budget (OMB) for
review and approval. CDC previously
published a ‘‘Proposed Data Collection
Submitted for Public Comment and
Recommendations’’ notice on May 29,
2018 to obtain comments from the
public and affected agencies. CDC
received three comments related to the
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
VerDate Sep<11>2014
20:00 Aug 27, 2018
Jkt 244001
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Direct
written comments and/or suggestions
regarding the items contained in this
notice to the Attention: CDC Desk
Officer, Office of Management and
Budget, 725 17th Street NW,
Washington, DC 20503 or by fax to (202)
395–5806. Provide written comments
within 30 days of notice publication.
Information Collection for
Tuberculosis Data from Panel
Physicians—Revision—National Center
for Emerging and Zoonotic Infectious
Diseases (NCEZID), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and
Prevention’s (CDC), National Center for
Emerging and Zoonotic Infectious
Diseases (NCEZID), Division of Global
Migration and Quarantine (DGMQ),
Immigrant, Refugee, and Migrant Health
Branch (IRMH), requests approval for a
revision of an existing information
collection. This project pertains to
collecting annual reports on certain
tuberculosis data from U.S. panel
physicians.
The respondents are panel physicians.
More than 760 panel physicians from
336 panel sites perform overseas predeparture medical examinations in
accordance with requirements, referred
to as technical instructions, provided by
DGMQs Quality Assessment Program
(QAP). The role of QAP is to assist and
guide panel physicians in the
implementation of the Technical
Instructions; evaluate the quality of the
overseas medical examination for U.S.bound immigrants and refugees; assess
potential panel physician sites; and
provide recommendations to the U.S.
Department of State in matters of
immigrant medical screening.
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
43875
To achieve DGMQ’s mission, the
Immigrant, Refugee and Migrant Health
branch (IRMH) works with domestic
and international programs to improve
the health of U.S.-bound immigrants
and refugees to protect the U.S. public
by preventing the importation of
infectious disease. These goals are
accomplished through IRMH’s oversight
of medical exams required for all U.S.—
bound immigrants and refugees who
seek permanent residence in the U.S.
IRMH is responsible for assisting and
training the international panel
physicians with the implementation of
medical exam Technical Instructions
(TI). Technical Instructions are detailed
requirements and national policies
regarding the medical screening and
treatment of all U.S.-bound immigrants
and refugees.
Screening for tuberculosis (TB) is a
particularly important component of the
immigration medical exam and allows
panel physicians to diagnose active TB
disease prior to arrival in the United
States. As part of the Technical
Instructions requirements, panel
physicians perform chest x-rays and
laboratory tests that aid in the
identification of tuberculosis infection
(Class B1 applicants) and diagnosis of
active tuberculosis disease (Class A,
inadmissible applicants). CDC uses
these classifications to report new
immigrant and refugee arrivals with a
higher risk of developing TB disease to
U.S. state and local health departments
for further follow-up. Some information
that panel physicians collect as part of
the medical exam is not reported on the
standard Department of State forms (DSforms), thereby preventing CDC from
evaluating TB trends in globally mobile
populations and monitoring program
effectiveness.
Currently, CDC is requesting this data
be sent by panel physicians once per
year. The consequences of reducing this
frequency would be the loss of
monitoring program impact and TB
burdens in mobile populations and
immigrants and refugees coming to the
United States on an annual basis.
Estimated annual burden is being
reduced by 1,640 hours per year. The
number of respondents is being reduced
by 17. Reductions are due to revised
estimates on burden time per response,
and the removal of four variables from
the data collection form and improved
IT capacity at most panel sites. The total
hours requested is 1,008. There is no
cost to the respondents other than their
time.
E:\FR\FM\28AUN1.SGM
28AUN1
43876
Federal Register / Vol. 83, No. 167 / Tuesday, August 28, 2018 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
International panel physicians ........................
TB Indicators Excel Spreadsheet ..................
Jeffrey M. Zirger,
Acting Chief, Information Collection Review
Office, Office of Scientific Integrity, Office
of the Associate Director for Science, Office
of the Director, Centers for Disease Control
and Prevention.
[FR Doc. 2018–18588 Filed 8–27–18; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–18–0600; Docket No. CDC–CDC–
2008–0079]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled CDC Model Performance
Evaluation Program (MPEP) for
Mycobacterium tuberculosis
Susceptibility Testing information
collection. CDC is requesting a threeyear approval for revision to the
previously approved project used to
monitor and evaluate performances and
practices among national laboratories M.
tuberculosis susceptibility testing.
DATES: CDC must receive written
comments on or before October 29,
2018.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2008–
00791 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
SUMMARY:
daltland on DSKBBV9HB2PROD with NOTICES
Number of
respondents
Type of respondents
VerDate Sep<11>2014
20:00 Aug 27, 2018
Jkt 244001
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffery M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
336
Average
burden per
response
(in hours)
1
3
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
CDC Model Performance Evaluation
Program (MPEP) for Mycobacterium
tuberculosis Susceptibility testing (OMB
#0920–0600, expiration 3/31/2019)—
Revision—National Center for HIV/
AIDS, Viral Hepatitis, STD, and TB
Prevention (NCHHSTP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The CDC is requesting a revision to
the approved information collection,
CDC Model Performance for
Mycobacterium tuberculosis Drug
Susceptibility Testing (OMB Control
Number 0920–0600). Clearance is
requested for a period of three years.
Revision of this information collection
will not require changes in the scope of
the study. This revision includes (a)
modification of the Participant Biosafety
Compliance Letter of Agreement; (b)
modification of the Instructions to
Participants Letter; (c) modification of
the MPEP Mycobacterium Results
Worksheet; (d) Request for approval of
a MPEP Mycobacterium tuberculosis
Minimum Inhibitory Concentration
(MIC) Results Form for laboratories that
perform Sensititre Drug Susceptibility
Testing (DST) to record MIC results; and
(e) reduction in request for burden
hours.
While the overall number of cases of
TB in the U.S. has decreased, rates still
remain high among foreign-born
persons, prisoners, homeless
populations, and individuals infected
with HIV in major metropolitan areas.
To reach the goal of eliminating TB, the
Model Performance Evaluation Program
for Mycobacterium tuberculosis
Susceptibility Testing is used to monitor
and evaluate performance and practices
among national laboratories performing
M. tuberculosis susceptibility testing.
Participation in this program is one way
E:\FR\FM\28AUN1.SGM
28AUN1
]]>Agencies
[Federal Register Volume 83, Number 167 (Tuesday, August 28, 2018)]
[Notices]
[Pages 43875-43876]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-18588]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-18-1102]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled Information Collection for Tuberculosis Data
from Panel Physicians to the Office of Management and Budget (OMB) for
review and approval. CDC previously published a ``Proposed Data
Collection Submitted for Public Comment and Recommendations'' notice on
May 29, 2018 to obtain comments from the public and affected agencies.
CDC received three comments related to the previous notice. This notice
serves to allow an additional 30 days for public and affected agency
comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to [email protected]. Direct written comments
and/or suggestions regarding the items contained in this notice to the
Attention: CDC Desk Officer, Office of Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by fax to (202) 395-5806. Provide
written comments within 30 days of notice publication.
Proposed Project
Information Collection for Tuberculosis Data from Panel
Physicians--Revision--National Center for Emerging and Zoonotic
Infectious Diseases (NCEZID), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and Prevention's (CDC), National
Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division
of Global Migration and Quarantine (DGMQ), Immigrant, Refugee, and
Migrant Health Branch (IRMH), requests approval for a revision of an
existing information collection. This project pertains to collecting
annual reports on certain tuberculosis data from U.S. panel physicians.
The respondents are panel physicians. More than 760 panel
physicians from 336 panel sites perform overseas pre-departure medical
examinations in accordance with requirements, referred to as technical
instructions, provided by DGMQs Quality Assessment Program (QAP). The
role of QAP is to assist and guide panel physicians in the
implementation of the Technical Instructions; evaluate the quality of
the overseas medical examination for U.S.-bound immigrants and
refugees; assess potential panel physician sites; and provide
recommendations to the U.S. Department of State in matters of immigrant
medical screening.
To achieve DGMQ's mission, the Immigrant, Refugee and Migrant
Health branch (IRMH) works with domestic and international programs to
improve the health of U.S.-bound immigrants and refugees to protect the
U.S. public by preventing the importation of infectious disease. These
goals are accomplished through IRMH's oversight of medical exams
required for all U.S.--bound immigrants and refugees who seek permanent
residence in the U.S. IRMH is responsible for assisting and training
the international panel physicians with the implementation of medical
exam Technical Instructions (TI). Technical Instructions are detailed
requirements and national policies regarding the medical screening and
treatment of all U.S.-bound immigrants and refugees.
Screening for tuberculosis (TB) is a particularly important
component of the immigration medical exam and allows panel physicians
to diagnose active TB disease prior to arrival in the United States. As
part of the Technical Instructions requirements, panel physicians
perform chest x-rays and laboratory tests that aid in the
identification of tuberculosis infection (Class B1 applicants) and
diagnosis of active tuberculosis disease (Class A, inadmissible
applicants). CDC uses these classifications to report new immigrant and
refugee arrivals with a higher risk of developing TB disease to U.S.
state and local health departments for further follow-up. Some
information that panel physicians collect as part of the medical exam
is not reported on the standard Department of State forms (DS-forms),
thereby preventing CDC from evaluating TB trends in globally mobile
populations and monitoring program effectiveness.
Currently, CDC is requesting this data be sent by panel physicians
once per year. The consequences of reducing this frequency would be the
loss of monitoring program impact and TB burdens in mobile populations
and immigrants and refugees coming to the United States on an annual
basis. Estimated annual burden is being reduced by 1,640 hours per
year. The number of respondents is being reduced by 17. Reductions are
due to revised estimates on burden time per response, and the removal
of four variables from the data collection form and improved IT
capacity at most panel sites. The total hours requested is 1,008. There
is no cost to the respondents other than their time.
[[Page 43876]]
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
International panel physicians........ TB Indicators Excel 336 1 3
Spreadsheet.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Acting Chief, Information Collection Review Office, Office of
Scientific Integrity, Office of the Associate Director for Science,
Office of the Director, Centers for Disease Control and Prevention.
[FR Doc. 2018-18588 Filed 8-27-18; 8:45 am]
BILLING CODE 4163-18-P
